Yuk Lam Lo
Director/Board Member at ZHAOKE OPHTHALMOLOGY LIMITED
Net worth: - $ as of 2024-05-30
Profile
Yuk Lam Lo is the founder of Hk Bio-Med Innotech Association.
He currently holds the following positions: Vice Chairman at Santai Eco Fishery Ltd., Chairman at Lo’s Associates Ltd., Vice Chairman at APlus OTC Health Group Ltd., Chairman at Lo & Associates, Chairman at GT Capital Investment Ltd., Independent Director at Sinovac Biotech Ltd., Independent Non-Executive Director at Luye Pharma Group Ltd., Director at Chinese Manufacturers' Association of Hong Kong, Senior Director at Questmark Asia Ltd., Director at Applied Research Council, Independent Non-Executive Director at Zhaoke Ophthalmology Ltd., Independent Non-Executive Director at HaploX Investment Holding Ltd., Member at The Hong Kong University of Science & Technology, Member at Hong Kong Baptist University, Executive Vice President at Asian College of Knowledge Management, Partner at Hongsen Investment Management Ltd., and President at Santai Biotechnology Research Institute Co. Ltd.
He has previously held positions as an Independent Non-Executive Director at CSPC Pharmaceutical Group Ltd.
from 2014 to 2021, Non-Executive Director at DIT Group Ltd.
from 2002 to 2011, Independent Director at Shangpharma Corp.
from 2010 to 2013, Director at Industry & Technology Development Council, and Member at Research Grants Council from 2007 to 2009.
Mr. Lo completed his undergraduate degree at The University of Waterloo.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-12-14 | 0 ( -.--% ) | - $ | 2024-05-30 | |
LUYE PHARMA GROUP LTD.
-.--% | 2023-01-19 | 0 ( -.--% ) | - $ | 2024-05-30 |
Yuk Lam Lo active positions
Companies | Position | Start |
---|---|---|
LUYE PHARMA GROUP LTD. | Director/Board Member | 2014-05-31 |
SINOVAC BIOTECH LTD. | Director/Board Member | 2006-02-28 |
ZHAOKE OPHTHALMOLOGY LIMITED | Director/Board Member | 2021-03-31 |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Director/Board Member | - |
The Hong Kong University of Science & Technology | Corporate Officer/Principal | - |
Santai Biotechnology Research Institute Co. Ltd. | President | - |
Hongsen Investment Management Ltd. | Corporate Officer/Principal | 2019-01-31 |
Applied Research Council | Director/Board Member | - |
Hk Bio-Med Innotech Association | Founder | - |
░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - |
Former positions of Yuk Lam Lo
Companies | Position | End |
---|---|---|
░░░░ ░░░░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Yuk Lam Lo
The University of Waterloo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
CSPC PHARMACEUTICAL GROUP LTD. | Health Technology |
DIT GROUP LIMITED | Finance |
SINOVAC BIOTECH LTD. | Health Technology |
LUYE PHARMA GROUP LTD. | Health Technology |
ZHAOKE OPHTHALMOLOGY LIMITED | Health Technology |
Private companies | 15 |
---|---|
Shangpharma Corp.
Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Health Technology |
Chinese Manufacturers' Association of Hong Kong
Chinese Manufacturers' Association of Hong Kong Miscellaneous Commercial ServicesCommercial Services The Chinese Manufacturers' Association of Hong Kong is a business organization based in Hong Kong, Hong Kong. and has subsidiaries in Hong Kong. The Chinese company was founded by Guoyou Lin. | Commercial Services |
Industry & Technology Development Council | |
Questmark Asia Ltd. | |
Research Grants Council | |
Santai Eco Fishery Ltd. | |
Applied Research Council | |
Lo’s Associates Ltd. | |
APlus OTC Health Group Ltd. | |
Lo & Associates | |
GT Capital Investment Ltd.
GT Capital Investment Ltd. Investment ManagersFinance GT Capital Investment Ltd. is an Independent Private Equity/Venture Capital firm founded in 2013 by Alan Au. GT Capital Investment Ltd. is headquartered in Hong Kong. | Finance |
Hk Bio-Med Innotech Association | |
Hongsen Investment Management Ltd. | |
Santai Biotechnology Research Institute Co. Ltd. | |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Yuk Lam Lo